Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2022
- Monday, August 8, 2022, 7:14
- Business
- Add a comment
SALT LAKE CITY, Aug. 8, 2022 /PRNewswire/ — Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on developing innovative products to treat metabolic and central nervous system (“CNS”) disorders, today announced financial results for the second quarter ended June 30, 2022…
About the Author
adminasapcorp has written 41562 stories on this site.